Systemic Lupus Erythematosus (SLE) is a complex autoimmune disease characterized by a range of symptoms and challenges in diagnosis and treatment. The discovery and utilization of specific biomarkers play a crucial role in the understanding and management of SLE. Among these, the Systemic Lupus Erythematosus Serum, identified as HBL107, provides significant potential for researchers and healthcare professionals alike.

What is HBL107?

HBL107 is a specialized serum designed for research purposes that targets various aspects of systemic lupus erythematosus. The serum is derived from human samples, ensuring high relevance to human health research. This product is pivotal for those studying the pathophysiology of SLE and its impact on patients.

Key Features

• Species Specificity: This serum is formulated from human samples, making it particularly relevant for studies involving human autoimmune responses.
• Sample Condition: It is created under stringent conditions, ensuring integrity and reliability for research applications.

Applications in Research

The utility of HBL107 extends to multiple facets of immunology and pathology:

• Autoimmune Disease Studies: It provides a basis for understanding the specific autoantibodies involved in SLE.
• Immuno-Oncology: Research into the immune system’s response to cancer often considers autoimmune disorders; HBL107 can contribute valuable insights.
• Comparative Studies: Researchers can utilize this serum for comparing lupus-related biomarkers with those from other autoimmune diseases.

Limitations

Despite its utility, it is essential to note that HBL107 is strictly for research use. It is not intended for diagnostic or therapeutic purposes in clinical settings. Researchers should consider this limitation when planning experiments and interpreting results.

Customization Options

Creative Bioarray is dedicated to supporting research needs, offering customizable specifications for the SLE serum that can align with specific project requirements. Researchers interested in tailoring this product can reach out for inquiries.

Conclusion

The Systemic Lupus Erythematosus Serum HBL107 represents a significant resource for researchers focused on autoimmune diseases. Its human-derived, high-quality serum provides critical insights that can help enhance our understanding and management of systemic lupus erythematosus.